Clin2
NCT07676669Possibly a fitNot yet recruiting

Comparing Two Medications for Bipolar I Depression

Bipolar 1 Depression

Treatments studied

Part of Mental health clinical trials.

This study compares two medications, Lumateperone and Cariprazine, to see which works better and has fewer side effects for people with bipolar I depression. It may help find a more effective treatment for your depressive symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
140 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with bipolar I disorder and are currently in a depressive episode.
  • You are taking a mood stabilizer (lithium or valproate) and have been on the same dose for at least 2 weeks.
  • You are not currently in a manic or mixed episode, and you do not have rapid cycling bipolar disorder.
  • You are not pregnant, breastfeeding, or at risk of harming yourself.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05913947Recruiting· Phase 4
Lithium or cariprazine for bipolar depression

This trial compares lithium versus cariprazine to treat an episode of depression in people with bipolar disorder. It may help find which medicine works better and is safer during the acute (active) phase of depression.

Aalborg
NCT07665073Not yet recruiting· Phase 4
Comparing risperidone and cariprazine for bipolar mania

This trial compares two medicines, risperidone and cariprazine, to see which works better for treating acute mania in bipolar disorder. It aims to find a more effective option to help calm severe mood episodes quickly.

NCT06372964Recruiting· Phase 3
Lumateperone for pediatric bipolar depression

This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.

Dothan, Alabama
NCT07747389Not yet recruiting· Phase 3
Lumateperone for major depressive disorder

This study tests whether the drug lumateperone can help people with moderate to severe depression. If you join, you may receive the study drug or a placebo (a pill with no active medicine) to see if it improves your symptoms.

NCT07699445Not yet recruiting· Phase 4
Lumateperone for weight and mood in bipolar depression

This study tests if lumateperone, a medication for bipolar depression, can also help with weight and aging in people with obesity. You may qualify if you have bipolar I depression and a body mass index (BMI) over 30.

Boston, Massachusetts
NCT05850689Recruiting· Phase 3
Lumateperone add-on for major depression that didn’t improve

This study tests whether adding lumateperone to an antidepressant helps adults with major depressive disorder (MDD) who haven’t improved enough after trying at least two different antidepressants. It may help reduce depressive symptoms more than antidepressants alone.

Huntsville, Alabama

Hear when a new Bipolar 1 Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.